AI used to develop treatment for childhood brain cancer


Using artificial intelligence, a new drug regime has been developed by scientists that can be used to treat diffuse intrinsic pontine glioma, a rare and aggressive form of brain cancer, in children. "In this study, use of AI has identified a drug combination which appears to have promise as a future treatment for some children with incurable brain cancer. It's exciting to think that it could become one of the first examples of a treatment proposed by AI going on to benefit patients," said Kristian Helin, chief executive of The Institute of Cancer Research in London.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.